Literature DB >> 32749488

Research and Development Costs of New Drugs-Reply.

Olivier J Wouters1, Martin McKee2, Jeroen Luyten3.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32749488     DOI: 10.1001/jama.2020.8651

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   157.335


× No keyword cloud information.
  2 in total

1.  Error in Data in Study of Estimated Cost of Bringing a Drug to Market.

Authors: 
Journal:  JAMA       Date:  2022-09-20       Impact factor: 157.335

2.  Antileishmanial Chemotherapy through Clemastine Fumarate Mediated Inhibition of the Leishmania Inositol Phosphorylceramide Synthase.

Authors:  John G M Mina; Rebecca L Charlton; Edubiel Alpizar-Sosa; Douglas O Escrivani; Christopher Brown; Amjed Alqaisi; Maria Paula G Borsodi; Claudia P Figueiredo; Emanuelle V de Lima; Emily A Dickie; Wenbin Wei; Robson Coutinho-Silva; Andy Merritt; Terry K Smith; Michael P Barrett; Bartira Rossi-Bergmann; Paul W Denny; Patrick G Steel
Journal:  ACS Infect Dis       Date:  2020-12-08       Impact factor: 5.084

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.